Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K N Franks

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Radiography (London, England : 1995)|May 4, 2023
Integrating the patients' voice in designing and delivering a research study: The Yorkshire Cancer Research funded PREHABS study's experienceC Burnett, J C Bestall, S Burke, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2020
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 PandemicC Faivre-Finn, J D Fenwick, K N Franks, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 17, 2017
UK Consensus on Normal Tissue Dose Constraints for Stereotactic RadiotherapyG G Hanna, L Murray, R Patel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 11, 2022
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative RadiotherapyP Diez, G G Hanna, K L Aitken, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Radiography (London, England : 1995)|May 4, 2023
Integrating the patients' voice in designing and delivering a research study: The Yorkshire Cancer Research funded PREHABS study's experienceC Burnett, J C Bestall, S Burke, et al.
Pilot and Feasibility Studies|December 16, 2016
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resectionM P Snee, L McParland, F Collinson, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 15, 2020
Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 PandemicC Faivre-Finn, J D Fenwick, K N Franks, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 17, 2017
UK Consensus on Normal Tissue Dose Constraints for Stereotactic RadiotherapyG G Hanna, L Murray, R Patel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 11, 2022
UK 2022 Consensus on Normal Tissue Dose-Volume Constraints for Oligometastatic, Primary Lung and Hepatocellular Carcinoma Stereotactic Ablative RadiotherapyP Diez, G G Hanna, K L Aitken, et al.
Pageof 2